Apollomics Class A Stock Probability of Future Stock Price Finishing Over 56.53
| APLM Stock | 9.88 0.61 5.82% |
Apollomics |
Apollomics Target Price Odds to finish over 56.53
The tendency of Apollomics Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over 56.53 or more in 90 days |
| 9.88 | 90 days | 56.53 | close to zero percent |
Based on a normal probability distribution, the odds of Apollomics to move over 56.53 or more in 90 days from now is close to zero percent (This Apollomics Class A probability density function shows the probability of Apollomics Stock to fall within a particular range of prices over 90 days) . Probability of Apollomics Class A price to stay between its current price of 9.88 and 56.53 at the end of the 90-day period is about 76.13 .
Given the investment horizon of 90 days Apollomics Class A has a beta of -0.74. This suggests as returns on the benchmark increase, returns on holding Apollomics are expected to decrease at a much lower rate. During a bear market, however, Apollomics Class A is likely to outperform the market. Additionally Apollomics Class A has an alpha of 0.4299, implying that it can generate a 0.43 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Apollomics Price Density |
| Price |
Predictive Modules for Apollomics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Apollomics Class A. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Apollomics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Apollomics is not an exception. The market had few large corrections towards the Apollomics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Apollomics Class A, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Apollomics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.43 | |
β | Beta against Dow Jones | -0.74 | |
σ | Overall volatility | 2.66 | |
Ir | Information ratio | 0.03 |
Apollomics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Apollomics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Apollomics Class A can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Apollomics Class A had very high historical volatility over the last 90 days | |
| Apollomics Class A has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 821 K. Net Loss for the year was (172.59 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Apollomics generates negative cash flow from operations | |
| About 47.0% of the company shares are held by company insiders | |
| Latest headline from globenewswire.com: Apollomics Uproleselan III |
Apollomics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Apollomics Stock often depends not only on the future outlook of the current and potential Apollomics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Apollomics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 74.4 M | |
| Cash And Short Term Investments | 37.8 M |
Apollomics Technical Analysis
Apollomics' future price can be derived by breaking down and analyzing its technical indicators over time. Apollomics Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Apollomics Class A. In general, you should focus on analyzing Apollomics Stock price patterns and their correlations with different microeconomic environments and drivers.
Apollomics Predictive Forecast Models
Apollomics' time-series forecasting models is one of many Apollomics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Apollomics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Apollomics Class A
Checking the ongoing alerts about Apollomics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Apollomics Class A help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Apollomics Class A had very high historical volatility over the last 90 days | |
| Apollomics Class A has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 821 K. Net Loss for the year was (172.59 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Apollomics generates negative cash flow from operations | |
| About 47.0% of the company shares are held by company insiders | |
| Latest headline from globenewswire.com: Apollomics Uproleselan III |
Check out Apollomics Backtesting, Apollomics Valuation, Apollomics Correlation, Apollomics Hype Analysis, Apollomics Volatility, Apollomics History as well as Apollomics Performance. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apollomics. If investors know Apollomics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Apollomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.15) | Revenue Per Share 0.023 | Quarterly Revenue Growth 2.623 | Return On Assets (0.63) | Return On Equity (1.49) |
The market value of Apollomics Class A is measured differently than its book value, which is the value of Apollomics that is recorded on the company's balance sheet. Investors also form their own opinion of Apollomics' value that differs from its market value or its book value, called intrinsic value, which is Apollomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apollomics' market value can be influenced by many factors that don't directly affect Apollomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Apollomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Apollomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apollomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.